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Summary: A rapid and specific assay for human serum caleitonin is described.
The total assay-time is under 24 h and uses double-antibody in combination with polyethylene glycol to separate
bound and free hormone.
The antibody has been checked for its affinity to human serum caleitonin by using a Scatchard plot. Geometric
dilution of sera from patients with medullary thyroid carcinoma showed a linear relationship with measured values
approximating those expected.
The use of Florisil to extract human serum caleitonin from sera to make "human calcitonin-free"-serum for standards
has been investigated. A series of 52 normal volunteers and 99 patients with medullary thyroid carcinoma or other
possible calcitonin-metabolism disorders have been examined. Only the medullary thyroid carcinoma-patients
showed significantly elevated results. In the other groups two patients with phaeochromocytoma and one patient
from 29 with bronchial carcinoma had elevated serum caleitonin levels.
Verbesserung der radioimmunologischen Calcitonin-Bestimmung
Zusammenfassung: Es wird ein verbesserter Radioimmunoassay für menschliches Caleitonin vorgestellt. Die Gesamt-
dauer der Bestimmung liegt unter 24 Stunden. Zur Trennung von gebundenem und freiem Hormon wird eine Doppel-
antikörper-Methode unter Zusatz von Polyethylenglykol eingesetzt. Das Antiserum wurde bezüglich seiner Affinität
zu menschlichein Caleitonin unter Einsatz des Scatchard-Plols untersucht. Serumverdünnungsreihen von Patienten
mit erhöhten Calcitonin-Konzeritrationen bei medullärem Schilddrüsenkarzinom lagen stets auf der Standardkurve.
Es werden Versuche zur Extraktion von menschlichem Caleitonin aus Patientenseren zur Herstellung eines "Calcito-
nin-freien" Serums beschrieben.
Wir untersuchten 52 stoffwechselgesunde Normalpersonen und 99 Patienten mit medullärem Schilddrüsenkarzinom,
Phaeochfomocytom, Bronchialkarzinom oder anderen Calcium-Stoffwechselstörungen. Nur in der Gruppe der Patien-
ten mit medullärem Schilddrüsenkarzinom fanden sich signifikant erhöhte Calcitonin-Konzentrationen. In den anderen
Gruppen fanden sich lediglich bei zwei Patienten mit einem Phaeochromocytom sowie bei einem Patienten von einer
Gruppe von 29 Patienten mit Bronchialkarzinom erhöhte Serum-Calcitonin-Konzentrationen.
Introduction
Since the introduction of a radioimmunoassay (RIA)
for human caleitonin (1, 2) the following problems have
not been fully resolved:
(1) Long assay time - usually in the order of several
days (1,2).
1) Supported in part by the Deutsche Forschungsgemeinschaft
(Spnderforschungsbereich 51) and by the Bundesministenum
für Forschung und Technologie (BMFT).
(2) Sensitivity - thus requiring an extraction step for
measurement in normal persons (3).
(3) Separation - the use of non-specific separation of
bound and free hormone (4).
This study has taken these points and developed an
assay which gives results inside 30 h, needs no extrac-
tion and uses a second antibody-polymer separation step
(5). To prove the reliability of the assay, parallel-dilution
tests, as well as a clinical study have been conducted over
a 12 month-period, including sera from patients with
medullary thyroid carcinoma, bronchial carcinoma and
calcium metabolism disturbances.
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Materials and Methods
The antiserum, coded 030377, donated by Professor R. Ziegler,
Ulm, was raised in a goat against synthetic 1-32 human calcit-
onin (CIBA-Geigy) (6).
The standard for labelling and in the assay was also the 1-32
human calcitonin from CIBA.
Standard curves were*set up in "human calcitonin-free"
serum (tested against a buffer-standard curve) except where
otherwise stated. Precipitating antiserum (2. Ab) (Donkey-anti-
sheep-goat) was obtained from Wellcome (D^6100 Darmstadt).
125I-human calcitonin was produced by a modified Hunter &
Greenwood method as published elsewhere for parathyrin (7)
and had a shelf-life of longer than 3 months. Purification of
label was effected by means of a 9 X 1 cm Sephadex G-10
column and the labelled human calcitonin stored in buffer 2
(see table 1).
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Fig. 1. Binding kinetics of the zero (x—^x) and 2.5 pg · liter1
(··—·) standards. 18 h pre-incubation 4 °C. Arrow




An antibody concentration of 1:10 000 (initial dilution)
was chosen to give a B0/T ratio of around 0.2 after an
incubation time of 6 h at 4 °C.
Affinity Studies
A Scatchard-plot carried out unter the assay conditions
gave a population of antibodies with an affinity constant
of 0.31 Χ 1011 liter - mof1 and shows why the assay can
be carried out in such a short time. A second population
of low affinity-high capacity antibodies with an affinity
constant of 0.28 Χ 109 liter · mol"1 was also seen.
Kinetic Studies of Tracer Binding
Figure 1 shows the kinetics of the zero and 2.5 μ% - liter"1
standards over a 7 h period after a 15 h preincubation at
4 °C. The second incubation was set at 4.5 h from these
results. The pre-incubation was set at 15 h — i.e. over-
night — as a part of the rationalisation programme. A
preincubation step was included to increase sensitivity
as shown for other peptide hormones (8).
Tab. 1. Assay details showing incubation, separation and counting
steps.
Pre-incubation 18 h 4 ° C
100 μΐ "Standard or serum
100 μΐ anti human calcitonin (1:10,000 initial dilution)
in ""buffer 2
Main Incubation 4.5 h 4 ° C
100 μΐ 125I-human calcitonin in buffer 2 (ca. 260 Bq)
Separation Reagent-addition +10 min at room
temperature
50 μΐ Sheep 7-globulin (10 μg)
50 μΐ Donkey-anti-sheep/goat precipitating serum
500 μΐ Polyethylene glycol (Μτ 6000; 60 g · liter'1)
Centrifugation
Counting
15 min 3000£ 4°C
Precipitate after aspiration of super-
natant.
2 min/tube - 10,000 counts in zero
standard
+ standards in "human calcitonin-free" serum, range 0.08-
l O M g - liter"1
++ buffer 2 = 0.05 mol/1 barbital buffer pH 7.4 containing 10 g
human serum albumin and 500,000 KIU aprotinin (Trasylol)
per liter.
Tracer - Preparation and Purification
Figure 2 shows the purification of the label over Ultrogel
AcA 54 after desalting of the reaction-mixture on Sepha-
80000 -
10 20 30 40 50
Fraction No.
70 80
Fig. 2. Elution profile of 12SI-human calcitonin on Ultrogel AcA
54 after Sephadex G-1 desalting. The maximum binding
to the antibody is shown (incubation time 6 h. Antibody
dilution 1:1000). The elution profile on Ultrogel AcA 34
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Tab. 2. Precision data - recovery, inter- and intra-assay coeffi-
cients of variation.
a) Recovery
In the range 0.15-10 μΐ · liter'1. The recovery of added human
calcitonin lay within the limits (χ ι SD) 99 8 t 13 3%
(n = 20).
b) Precision










































dex G-10. It can be seen that no further purification than
Sephadex G-10 is required as over 95 % immunoreactivity
is distributed over a single peak. The small forepeak (peak
IV) has little or no effect on the assay system.
Preparation of "human calcitonin free serum"
Table 3 shows several serum components before and after
extraction (100 g Florisil per liter serum). Figure 3 shows
the radioactivity bound before and after Florisil in 7 sera
and table 3 the electrophoretic pattern and concentration
of several serum components before and after treatment.
Figures 4a—4d show the effect of varying one component
of the extraction system. The basic extraction system con-
sisted of Florisil 200 g · liter"1 and an extraction time of
30 min at room temperature under constant shaking. The
variable parameter is shown in the x-axis of figures 4 a—
4d. The tracer purity (tracer 10 weeks old) was estimated
to be between 50 % and 60 % using column chromato-
graphy (estimated purity 52%) and excess antibody bind-







Fig. 3. Effect of Florisil® on immunoreactive human calcitonin in
several serum and plasma samples. B.R., F., K. G. are patient
sera and K7 -Kl 0 outdated blood plasma samples.
Tab. 3. EJfect of Florisil extraction on certain serum components













































showed that Florisil extracted immunoreactive human
calcitonin to within the expected limits. The system
chosen for the extraction of the sera shown in figure 3
was that given above.
Assay Conditions
Assay Standard Curves
Figure 5 shows a typical standard curve for the human
calcitonin assay. The effect of changing the amount of
serum in one experiment had the following effect on
the 50 % intercept:
With 50 μΐ serum the 50 % intercept was 2.86 μg ' liter"1,
with 100 μΐ serum, 1.55 Mg · liter"1, and with 200 μΐ
serum, 1.09 Mg ' liter"1. The 50 μΐ assay showed a
pronounced "hook-effect" which was not present with
larger serum amounts.
In the earlier studies, 15 % polyethyleneglycol was used
as precipitant as also described elsewhere for parathyrin
(9). Owing to unspecific effects with sera from patients
with disproteinaemia — mainly dialysis patients, or those
with Waldenstrom's disease - this method was changed
to a double-antibody procedure, especially when the
latter could be performed rapidly (5).
Parallelism Studies
Figure 6 shows the effect of diluting two sera from
patients with medullary-thyroid carcinoma, serum A from
a dialysis patient and serum Β from a patient with normal
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Figs. 4a-4d. Extraction of 125I-human calcitonin from serum. The expected extraction is 0.50-0.60 (between the dotted lines)
(Tracer purity - estimated at 0.52-0.58). Figure 4a shows effect of varying the Florisil concentration, Figure 4b
shows the effect of varying serum, Figure 4 c shows the effect of varying the amounts of 125I-human calcitonin
and Figure 4d the effect of varying the extraction time.
The "standard system" consisted of Florisil 200 g · liter"1 serum, 1 Mg · liter"1 human calcitonin, extraction time 30
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Fig. 5. Typical standard curve for human calcitonin-radioimmuno·!
assay. 0.50 intercept 0.88 Mg * liter"1. The dotted line
shows the lower limit of detection (0.08 Mg * liter"1).
Fig. 6. Serial dilution of two serum samples.
Serum A - patient with medullary thyroid carcinoma and
renal failure (· ·)
Serum B - patient with medullary thyroid carcinoma and
normal renal function (·—^·).
The results are the mean and standard dilution of triplicate
measurements.
renal function, using the 2. Ab separation technique. Both
were diluted with human calcitonin-free serum and
diluted out as expected. The results shown are mean and
standard deviation of triple determinations.
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Fig. 7 a. Scattergram of the patient groups. Dotted line shows upper limit of normal range (< 0.05-0.30 Mg · liter"1).
Key: MEA II = multiple endocrine neoplasia type II.
Intra* and Interassay Coefficients of Variation (CV)
Table 2 shows the intra- and interassay CV over the
whole range of the standard curve. The interassay CV
was carried out over a 3 month-period.
Clinical Studies
Figure 7 a shows the immunoreactive human calcitonin-
levels found in 52 normal patients compared with a group
of 8 patients with medullary thyroid carcinoma, 29
patients with bronchial tumors, 5 phaeochromocytoma
patients, and 57 patients with calcium metabolism dis-
orders (renal stones, hyper- and hypoparathyruiaemia).
Only the patients with medullary thyroid carcinoma
and confirmed multiple endocrine adenoma H-cases
showed significantly elevated human calcitonin levels.
The normal collective had a normal calcium metabolism,
were aged 18-67 years and were distributed evenly
between the sexes (cJ, 9 = 26). The difference in human
calcitonin levels between the sexes in the normal
collective was not statistically significant (p 0.2 (Wil-
coxpn Rank test)). Six patients with phaeochromocy-
toma were studied and their human calcitonin levels
ranged from 0.04-1.28 Mg · liter"1. Figure 7b shows
patients with disturbed calcium metabolism, measured
at the same time, including the patients with medullary
thyroid carcinoma and 14 normal volunteers. Two
dialysis patients showed slightly elevated values. Figure 8
shows the pre- and postoperative human calcitonin
levels in a patient with lung metastases from a medullary
thyroid carcinoma during cytostatic treatment. Clinical
symptoms correlated well, but cytostatic treatment
had to be discontinued due to severe side-effects in the
haematopoietic system.
Discussion
Although the assay for human calcitonin in serum is very
rarely an emergency one, the need for rapid and sensitive
assays is present, especially in rationalisation of assay
procedures; and also because of the theoretical consid-
eration that the quicker the assay, the less the likelihood
that degradation of the hormone may give rise to false
results. The affinity constant of the antiserum used here
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Fig. 7 b. Scattergram of normal volunteers and patients with selected calcium metabolism disorders (including patients with medullary
thyroid carcinoma) measured in a single assay.
Key: 2 and 3 (Dialysis group) = secondary and tertiary hyperparathyrinaemia; Parathyroidectomised patients without re-
implantation. Dotted line shows upper limit of normal range (< 0.05-0.30 Mg · liter"1)
M.C. = Mammary carcinoma
PNS = Paraneoplastic syndrome
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Fig. 8. Patient T.S. (9 72a). Control of serum calcitonin levels
under chemotherapy for medullary thyroid carcinoma
with lung metastases.
Dotted line shows upper limit of normal range (<0.05-
0.30Mg· liter"1).
Serum calcium 2.4 mmol · li^er"1, serum phosphorus
0.9 mmol · liter"1
t, 4 Incidence of lung metastases (Xray scans)
makes it possible to run such quick assays without loss
of sensitivity. The addition of aprotinin to the buffer system
was to prevent protease activity — or at least hinder it.
Non equilibrium assay conditions have been shown to be
more sensitive than equilibrium ones (10), and this,
coupled with pre-incubation, improves the sensitivity/assay
time relationship.
The use of non-specific precipitation methods was tried
out at first using polyethyleneglycol, but due to the tin-
specific effects in disproteinaemic sera (11), this was
only used until a double-antibody technique was
perfected. The disadvantage of adding double-antibody
alone was the slow kinetics (5) but with addition of poly-
ethyleneglycol to a final concentration of 30—50 g -
liter"1 this reaction was speeded up by over 1000-fold
(5), so that the method was as quick as polyethylene-
glycol and quicker than charcoal (2) without the time
dependency of the latter. The quality-control of the
assay is satisfactory as seen in table 2.
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The capacity of the assay to measure human calcitonin
accurately is seen in the assay of sequentially diluted
sera where the expected value lay very near to the meas-
ured value. The acquisition of human calcitonin-free
serum by extraction with Florisil, although not all sera
are useable.
It has been observed that when sera are not frozen at
under -20 °C within 24 h of receipt that a loss of
immunoreactivity is seen, i.e. the binding in the assay
falls off, giving rise to falsely elevated results. Treatment
with Florisil does not restore the immunoreactivity.
Samples F and BR in figure 3 show this effect, and it must
be put forward that this is not due to a change in human
calcitonin (which would have to be generated!) but to
degradation of component(s), perhaps in the complement
system, which enhance the antigen-antibody reaction.
The use of the human ealcitonin assay in clinical diag-
nosis has been intensively investigated and also
reports have been given where serum human calcitonin
levels are raised in patients with various tumors (3,12)
other than medullary thyroid carcinoma. In this
laboratory, consistenly elevated-levels have only been
found in patients with medullary thyroid carcinoma.
In two patients, mother and daughter, with phaeochromo-
cytoma removed 6 months and 12 years before, but
without confirmed medullary thyroid carcinoma elevated
human calcitonin was found which agree with the symp-
toms of multiple endocrine neoplasia type II (13). The
value of human calcitonin as a general tumor marker is
doubtful in the light of the present study. In the
patients with bronchial carcinoma, serum corticotropin
levels were also normal (Müller, O. A., unpublished results)
in contrast to other studies (14,15). One reason for
this discrepancy may very well be due to the specificity
of the antisera used, i.e. whether it is C- or N-regional
specific (15), and future studies must be carried out to
determine the specificity of the antiserum to different
regions of human calcitonin.
The use of the human calcitonin-assay using this anti-
sera seems to be limited to the detection and follow-
up of medullary thyroid carcinoma, and multiple endo-
crine adenoma type II in which production of human
calcitonin can occur both in the adrenal medulla and
the C-cells of the thyroid as both have a common em-
bryological source.
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HDL-Cholesterin-Spiegel ein geringeres Risiko für die
Entwicklung von Arteriosklerose und koronaren Herz-
krankheiten, solche mit einer niedrigen HDL-Cholesterin
Konzentration ein erhöhtes Risiko besitzen.
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